Acquired Hemophilia Treatment Market 2020 by Types of Therapy, Regional Overview, Key Players, Industry Growth, Demand, Opportunities and Forecast to 2025
The global acquired hemophilia treatment market was USD 2,181.7 million in 2018 and is set to reach USD 2,700.9 million over the forecast period. The exorbitant cost associated with the bypassing agents employed as hemostatic therapy to control bleeding episodes will hamper the acquired hemophilia treatment market growth.
View full press release